Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Katsunori JINNOUCHI"'
Autor:
Kunio Hieshima, Seigo Sugiyama, Akira Yoshida, Noboru Kurinami, Tomoko Suzuki, Hiroko Ijima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Tomio Jinnouchi, Hideaki Jinnouchi
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 617-625 (2020)
Abstract Aims/Introduction The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often encountered who are hyperglycemic, but urine glucose test strip‐negative, who remain nega
Externí odkaz:
https://doaj.org/article/ea9220535e6942029004990f72a09126
Autor:
Noboru Kurinami, Kenji Ashida, Seigo Sugiyama, Yoko Morito, Nao Hasuzawa, Akira Yoshida, Ayami Morita, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Tomio Jinnouchi, Hideaki Jinnouchi, Masatoshi Nomura
Publikováno v:
Internal Medicine. 62:987-993
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91299ea9c0a422384606c0ff3085a844
https://doi.org/10.2169/internalmedicine.9773-22
https://doi.org/10.2169/internalmedicine.9773-22
Autor:
Fumio Miyamoto, Katsunori Jinnouchi, Tomoko Suzuki, Noboru Kurinami, Hideaki Jinnouchi, Hiroko Ijima, Tomio Jinnouchi, Keizo Kajiwara, Kunio Hieshima, Seigo Sugiyama, Akira Yoshida
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 617-625 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 617-625 (2020)
Aims/Introduction The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often encountered who are hyperglycemic, but urine glucose test strip‐negative, who remain negative for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3cf8e781781766de9d4e051908fcda
https://doi.org/10.1111/jdi.13191
https://doi.org/10.1111/jdi.13191
Autor:
Seigo Sugiyama, Akira Yoshida, Katsunori Jinnouchi, Tomio Jinnouchi, Keizo Kajiwara, Tomoko Suzuki, Noboru Kurinami, Motoko Tanaka, Fumio Miyamoto, Kunio Hieshima, Hideaki Jinnouchi
Publikováno v:
Journal of Clinical Medicine Research
Background: Renal function deterioration accompanied by an acute decrease in estimated glomerular filtration rate (eGFR) was observed early after starting sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapy. It is unclear how much and how frequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3bfa5a471e47ee66f2e7316bbc4e31c
https://doi.org/10.14740/jocmr4351
https://doi.org/10.14740/jocmr4351
Autor:
Seigo Sugiyama, Hideaki Jinnouchi, Kunio Hieshima, Noboru Kurinami, Katsunori Jinnouchi, Akira Yoshida, Tomoko Suzuki, Keizo Kajiwara, Fumio Miyamoto, Tomio Jinnouchi
Publikováno v:
NEJM Evidence. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f6081fedb6d5592b611e02b8c25e3c5
https://doi.org/10.1056/evidoa2100052
https://doi.org/10.1056/evidoa2100052
Autor:
Noboru Kurinami, Seigo Sugiyama, Tomio Jinnouchi, Katsunori Jinnouchi, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Tomoko Suzuki, Motoko Tanaka, Hideaki Jinnouchi, Keizo Kajiwara
Publikováno v:
Journal of Clinical Medicine Research
Background: Large randomized clinical trials of patients with type 2 diabetes mellitus (T2DM) and at high risk for cardiovascular disease revealed that sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduced renal events. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9548e6321e490ea0895c4c62e150d14
https://doi.org/10.14740/jocmr3761
https://doi.org/10.14740/jocmr3761
Publikováno v:
Cureus
Diabetes mellitus is a heterogeneous and complex metabolic disorder characterized by hyperglycemia secondary to either resistance to insulin actions on the liver and peripheral tissues, insufficient insulin secretion from pancreatic β-cells, or both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2861e7ff2ad6fe38dfca754f343b38a4
https://doi.org/10.7759/cureus.14354
https://doi.org/10.7759/cureus.14354
Autor:
Keizo Kajiwara, Seigo Sugiyama, Kunio Hieshima, Katsunori Jinnouchi, Hiromi Tsuyuno, Akira Yoshida, Tomio Jinnouchi, Hideaki Jinnouchi, Noboru Kurinami, Tomoko Suzuki, Kiyoko Iwamoto
Publikováno v:
Diabetes research and clinical practice. 182
We investigated the effects of the SGLT2 inhibitor luseogliflozin on blood and urinary glucose and body weight.Luseogliflozin 2.5 mg was administered once daily for 24 weeks to 30 outpatients with type 2 diabetes. Urinary glucose concentration, conti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eada9f55ea806b15215586645bbecb9a
https://pubmed.ncbi.nlm.nih.gov/34119556
https://pubmed.ncbi.nlm.nih.gov/34119556
Publikováno v:
Cureus
The overall goal in the treatment of type 2 diabetes mellitus (T2DM) is remission. However, the effects of a sodium-glucose cotransporter 2 inhibitor (SGLT2i) on remission of T2DM are unknown. We herein report a case involving an overweight 43-year-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9be64c722f2c35e672a723c886752e7
https://doi.org/10.7759/cureus.7110
https://doi.org/10.7759/cureus.7110
Autor:
Hiroyuki Nishimura, Tomio Jinnouchi, Akira Yoshida, Kunio Hieshima, Keizo Kajiwara, Fumio Miyamoto, Seigo Sugiyama, Hideaki Jinnouchi, Katsunori Jinnouchi, Tomoko Suzuki, Motoko Tanaka, Noboru Kurinami
Publikováno v:
Journal of Clinical Medicine Research
Background: We examined whether the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin can improve urine albumin-to-creatinine ratio (UACR) associated with a reduction in body weight or body fat in patients with type 2 diabetes mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9704a470f3340ed58efa851f4a34e306
http://europepmc.org/articles/PMC5916535
http://europepmc.org/articles/PMC5916535